Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10064
mi
from
Ormond Beach, FL
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10064
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
Savannah, GA
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
Savannah, GA
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 11501
mi
from
Overland Park, KA
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 11501
mi
from
Overland Park, KA
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10073
mi
from
Wichita, KA
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10073
mi
from
Wichita, KA
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10158
mi
from
Bethesda, MD
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10158
mi
from
Bethesda, MD
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10138
mi
from
North Dartmouth, MA
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10138
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10531
mi
from
Plymouth, MN
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10531
mi
from
Plymouth, MN
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
St. Louis, MO
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10642
mi
from
Bozeman, MT
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10642
mi
from
Bozeman, MT
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10105
mi
from
High Point, NC
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10105
mi
from
High Point, NC
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
Raleigh, NC
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10522
mi
from
Canton, OH
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10522
mi
from
Canton, OH
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
Cincinnati, OH
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
Oklahoma City, OK
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
Tulsa, OK
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
Tulsa, OK
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10132
mi
from
Eugene, OR
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10132
mi
from
Eugene, OR
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
Medford, OR
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
Medford, OR
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
Portland, OR
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 1366
mi
from
Charleston, SC
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 1366
mi
from
Charleston, SC
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10517
mi
from
Spartanburg, SC
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10517
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
Dallas, TX
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site 10149
mi
from
New Braunfels, TX
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site 10149
mi
from
New Braunfels, TX
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated:  6/27/2013
Teva Investigational Site
mi
from
San Antonio, TX
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Teva Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (2.5 Mcg and 5 Mcg Once Daily) Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Adolescents (12 to 17 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated:  7/10/2013
1268.17.01003 Boehringer Ingelheim Investigational Site
mi
from
Stockton, CA
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (2.5 Mcg and 5 Mcg Once Daily) Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Adolescents (12 to 17 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated: 7/10/2013
1268.17.01003 Boehringer Ingelheim Investigational Site
mi
from
Stockton, CA
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (2.5 Mcg and 5 Mcg Once Daily) Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Adolescents (12 to 17 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated:  7/10/2013
1268.17.01036 Boehringer Ingelheim Investigational Site
mi
from
Normal, IL
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (2.5 Mcg and 5 Mcg Once Daily) Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Adolescents (12 to 17 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated: 7/10/2013
1268.17.01036 Boehringer Ingelheim Investigational Site
mi
from
Normal, IL
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (2.5 Mcg and 5 Mcg Once Daily) Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Adolescents (12 to 17 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated:  7/10/2013
Boehringer Ingelheim Investigational Site
mi
from
Baltimore, MD
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (2.5 Mcg and 5 Mcg Once Daily) Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Adolescents (12 to 17 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated: 7/10/2013
Boehringer Ingelheim Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (2.5 Mcg and 5 Mcg Once Daily) Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Adolescents (12 to 17 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated:  7/10/2013
1245.25.10112 Boehringer Ingelheim Investigational Site
mi
from
Columbia, MO
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (2.5 Mcg and 5 Mcg Once Daily) Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Adolescents (12 to 17 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated: 7/10/2013
1245.25.10112 Boehringer Ingelheim Investigational Site
mi
from
Columbia, MO
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (2.5 Mcg and 5 Mcg Once Daily) Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Adolescents (12 to 17 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated:  7/10/2013
1268.17.01008 Boehringer Ingelheim Investigational Site
mi
from
Bellevue, NE
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (2.5 Mcg and 5 Mcg Once Daily) Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Adolescents (12 to 17 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated: 7/10/2013
1268.17.01008 Boehringer Ingelheim Investigational Site
mi
from
Bellevue, NE
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (2.5 Mcg and 5 Mcg Once Daily) Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Adolescents (12 to 17 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated:  7/10/2013
205.456.01001 Boehringer Ingelheim Investigational Site
mi
from
Rockville Centre, NY
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (2.5 Mcg and 5 Mcg Once Daily) Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Adolescents (12 to 17 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated: 7/10/2013
205.456.01001 Boehringer Ingelheim Investigational Site
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (2.5 Mcg and 5 Mcg Once Daily) Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Adolescents (12 to 17 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated:  7/10/2013
Boehringer Ingelheim Investigational Site
mi
from
Cincinnati, OH
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (2.5 Mcg and 5 Mcg Once Daily) Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Adolescents (12 to 17 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated: 7/10/2013
Boehringer Ingelheim Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (2.5 Mcg and 5 Mcg Once Daily) Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Adolescents (12 to 17 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated:  7/10/2013
Boehringer Ingelheim Investigational Site
mi
from
Charleston, SC
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (2.5 Mcg and 5 Mcg Once Daily) Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Adolescents (12 to 17 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated: 7/10/2013
Boehringer Ingelheim Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma
Comparison of the Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  7/23/2013
Teva Investigational Site 10163
mi
from
Costa Mesa, CA
Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma
Comparison of the Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 7/23/2013
Teva Investigational Site 10163
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated:  7/26/2013
Teva Investigational Site 10077
mi
from
Homewood, AL
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated: 7/26/2013
Teva Investigational Site 10077
mi
from
Homewood, AL
Click here to add this to my saved trials
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated:  7/26/2013
Teva Investigational Site 34
mi
from
Phoenix, AZ
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated: 7/26/2013
Teva Investigational Site 34
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated:  7/26/2013
Teva Investigational Site 10163
mi
from
Costa Mesa, CA
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated: 7/26/2013
Teva Investigational Site 10163
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated:  7/26/2013
Teva Investigational Site 15
mi
from
Fountain Valley, CA
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated: 7/26/2013
Teva Investigational Site 15
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated:  7/26/2013
Teva Investigational Site
mi
from
Huntington Beach, CA
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated: 7/26/2013
Teva Investigational Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated:  7/26/2013
Teva Investigational Site
mi
from
Los Angeles, CA
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated: 7/26/2013
Teva Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated:  7/26/2013
Teva Investigational Site 10061
mi
from
Roseville, CA
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated: 7/26/2013
Teva Investigational Site 10061
mi
from
Roseville, CA
Click here to add this to my saved trials
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated:  7/26/2013
Teva Investigational Site
mi
from
San Diego, CA
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated: 7/26/2013
Teva Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated:  7/26/2013
Teva Investigational Site 10133
mi
from
Denver, CO
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated: 7/26/2013
Teva Investigational Site 10133
mi
from
Denver, CO
Click here to add this to my saved trials
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated:  7/26/2013
Teva Investigational Site 1345
mi
from
Miami, FL
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated: 7/26/2013
Teva Investigational Site 1345
mi
from
Miami, FL
Click here to add this to my saved trials
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated:  7/26/2013
Teva Investigational Site 10064
mi
from
Ormond Beach, FL
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated: 7/26/2013
Teva Investigational Site 10064
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated:  7/26/2013
Teva Investigational Site
mi
from
Savannah, GA
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated: 7/26/2013
Teva Investigational Site
mi
from
Savannah, GA
Click here to add this to my saved trials
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated:  7/26/2013
Teva Investigational Site 10073
mi
from
Wichita, KA
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated: 7/26/2013
Teva Investigational Site 10073
mi
from
Wichita, KA
Click here to add this to my saved trials
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated:  7/26/2013
Teva Investigational Site 10070
mi
from
Owensboro, KY
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated: 7/26/2013
Teva Investigational Site 10070
mi
from
Owensboro, KY
Click here to add this to my saved trials
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated:  7/26/2013
Teva Investigational Site 10158
mi
from
Bethesda, MD
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated: 7/26/2013
Teva Investigational Site 10158
mi
from
Bethesda, MD
Click here to add this to my saved trials
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated:  7/26/2013
Teva Investigational Site 10571
mi
from
Gaithersburg, MD
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated: 7/26/2013
Teva Investigational Site 10571
mi
from
Gaithersburg, MD
Click here to add this to my saved trials
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated:  7/26/2013
Teva Investigational Site 10177
mi
from
Wheaton, MD
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated: 7/26/2013
Teva Investigational Site 10177
mi
from
Wheaton, MD
Click here to add this to my saved trials
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated:  7/26/2013
Teva Investigational Site
mi
from
St. Louis, MO
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma
Status: Enrolling
Updated: 7/26/2013
Teva Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials